UUID: SEEADDDC- -D75E- 458E- 8CDC- C118A6ER44eZl§a
TCGA- YL- ABSB- BlA- PR

III IIIIIIIIIIIIIIIIIII|I|II|II|I|IIIIII||I||IIIII|IIIIIII|I||||||IIIad
IIIIIIIIIIIII IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII
III IIIIIIIIIIIIIIIIIIIlIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII

PROSTATE AND PELVIC LYMPH NODES; RADICAL PROSTATECTOMY:

TUMOR PROCUREMENT:

HISTOLOGIC TYPE
ACINAR ADENOCARCINOMA

HISTOLOGIC GRADE (PRIMARY PATTERN+SECONDARY PATTERN = GLEASON SCORE):

4+5=9

TERTIARY PATTERN NOT PRESENT 6 W 1“; {+4 10"”

PERCENTAGE OF DIFFERENT GLEASON PATTERNS

NOTDETERMINED dx MW W

TUMOR LOCATION
APEX
MID
BASE
ANTERIOR
RIGHT
LEFT

POSTERIOR 2(ng .5

RIGHT

LEFr M ﬂzwwl 41, («z/Aw

EXTRA-PROSTATIC EXTENSION

\Nas aim/5

<~ L1. NIT-daili— W W ‘>

’I— VAL
SITE 0F EXT RA-PROSTATIC EXTENSION )

ANTERIOR
RIGHT
LEFI'
SEMINAL VESICAL INVASION
ABSENT
SURGICAL MARGINS
INVOLVED BY INVASIVE CARCINOMA
APEX
BASE
ANTERIOR
RIGHT
LEFT
NATURE OF POSITIVE MARGINS
IN AREAS OF INTRA-PROSTATIC INCISION
IN AREAS OF EXTRA-PROSTATIC EXTENSION
EXTENT OF POSITIVE MARGINS
MULTIFOCAL
MILLIMETRIC EXTENT OF POSITIVE MARGINS: NOT DETERMINED
GLEASON GRADE OF CARCINOMA PRESENT AT THE POSITIVE MARGINS
NOT DETERMINED
LYMPHOVASCULAR INVASION
NOT DETERMINED
PERINEURAL INVASION
NOT DETERMINED
TUMOR VOLUME
PROPORTION OF PROSTATE INVOLVED BY CARCINOMA: _60%
TREATMENT EFFECT ON CARCINOMA
NOT APPLICABLE
LYMPH NODES
RIGHT PELVIC
NUMBER OF NODES INDENTIFIED: _1__

§4,.gz)/oza//LI

Case is

Initials

 

NUMBER OF NODES INVOLVED BY METASTASIS: _0___
LEFT PELVIC
NUMBER OF NODES INDENTIFIED: _2_
NUMBER OF NODES INVOLVED BY METASTASIS: _0_
ADDITIONAL PATHOLOGIC FINDINGS
NONE
PATHOLOGICAL STAGING
pT3a
pNO
pMX

 

 

 

TCGA Pathologic Diagnosis Discrepancy Form

v» .
5‘15 5;}!

 

 

 

 

Tissue snurce Site [1‘55]: _

instructions; The TCGA Pathologic Diagnosis Discrepancy Form should be completed when the pathologic diagnosis
documented on the initial pathology report for a case submitted for TCGA is inconsistent with the diagnosis provided on the
Case Quality Control Form completed for the submitted case.

 

, TSS Identiﬁer:

CompIeted By {Interviewer Name on 0pchIinica):

TSS Unique Patient Identiﬁer:

~Completed Date:

 

Diagnosis information

 

 

 

 

 

 

 

 

 

 

 

 

 

it Data Element Entry Alternatives Working Instructions
P th I ' D' . Pgovide tlhe dI‘agInosis/ histoflogilc WbWIISIIdIfun-lfme? on
a 0 OglC mgnosxs ‘ ’44 » “3.15.3 , t einina pat oogyrcport or iis case. r e isto ogy or
1 Provided on initial {WWI this case is mixed. provide all listed subtypes.
. .. . " M4 4*
Pathology Report 50.71456» I; (‘3' “’ /
Stimgggeigmsgi dam W “WWW 222i5:33:33.‘23§’.§L”§§3§§I§;$37,122:?W
1' $3 I e A ' ’ " I r .'
2 for TCGA. as reflected (4’va 3- f 171 V (f
. .. .,
on the CQCF.
[Discrepancy between Pathology Report and Case Quality Control Form
3 Provide the reason for I’roziclie a reason (fiescgihing wihy the diagnosis on the initial
, - \ , A ... pat oogy report ort is case snotconsistentwitii the
Ulitﬂgggeﬂgzlgéihdogy ”lbs/Hm «WY/[Jr diagnosis selected on the TCGA Case Quality Control Form.
r' ortand the TCGA
Ip ,. ‘ fat/we?) NW ' [3117791) 7
Case Quality (.ontroi * L -e: , .9
Form.
WW 4
(Wail/L's“ 25311:“)
Name Of'I‘SS Reviewing Provide the name of the pathologist who reviewed this case
4» Pathologist or I” TCGA'
Biorepository Director

 

I acknowledge that the above information pmvided by my institution is true and correct and has been quality controlled.

 

TSS Reviewing BatKologist or Biorepository Director

Date

1 acknowledge that the above Information provided by my institution is true and correct and has been quality controlled. The Attending Pathologist or the
Department Chairman has been informed or is aware of the above discrepancy In diagnoses.

Principaiinvestigétor Signature

 

Date

 

 

